ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesL30.1

L30.1

Billable

Dyshidrosis [pompholyx]

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 L30.1 is a billable code used to indicate a diagnosis of dyshidrosis [pompholyx].

Key Diagnostic Point:

Dyshidrosis, also known as pompholyx, is a dermatological condition characterized by the sudden onset of small, itchy blisters on the palms of the hands and soles of the feet. The blisters are often filled with clear fluid and can be quite painful. The condition is believed to be associated with factors such as stress, allergies, and exposure to certain metals or chemicals. The anatomy involved primarily includes the epidermis and dermis of the skin, where the vesicular lesions form. Disease progression can vary, with some patients experiencing recurrent episodes that may last for weeks, while others may have a chronic form of the condition. Diagnostic considerations include a thorough clinical examination and patient history to rule out other skin disorders such as eczema or contact dermatitis. Patch testing may be warranted to identify potential allergens. Management typically involves topical corticosteroids, antihistamines, and in severe cases, systemic therapies. Understanding the triggers and implementing preventive measures is crucial for effective long-term management.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Diagnostic complexity: Requires differentiation from other vesicular skin conditions.
  • Treatment complexity: May involve multiple treatment modalities based on severity.
  • Documentation requirements: Detailed patient history and treatment response must be documented.
  • Coding specificity: Requires accurate coding to reflect the specific type of dermatitis.

Audit Risk Factors

  • Common coding errors: Misclassification with other dermatitis codes.
  • Documentation gaps: Incomplete patient history or treatment documentation.
  • Billing challenges: Potential denials due to lack of specificity in coding.

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Allergy and Immunology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Dyshidrosis affects a significant portion of the population, particularly adults aged 20-40. Its impact on quality of life can be substantial due to the discomfort and potential for secondary infections from scratching. Understanding the epidemiology of dyshidrosis can help healthcare providers implement effective management strategies and improve patient outcomes. Quality measures may include monitoring treatment efficacy and patient satisfaction, which can influence healthcare utilization patterns.

ICD-9 vs ICD-10

Dyshidrosis affects a significant portion of the population, particularly adults aged 20-40. Its impact on quality of life can be substantial due to the discomfort and potential for secondary infections from scratching. Understanding the epidemiology of dyshidrosis can help healthcare providers implement effective management strategies and improve patient outcomes. Quality measures may include monitoring treatment efficacy and patient satisfaction, which can influence healthcare utilization patterns.

Reimbursement & Billing Impact

Reimbursement considerations include ensuring that the diagnosis is clearly linked to the services provided. Common denials may arise from insufficient documentation or incorrect coding. It is essential to provide detailed notes that justify the medical necessity of treatments, especially for recurrent cases. Familiarity with payer-specific guidelines can enhance the likelihood of successful claims.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for L00-L99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by L30.1?

L30.1 specifically covers dyshidrosis (pompholyx), which is characterized by vesicular eruptions on the palms and soles. It may also include recurrent episodes triggered by environmental factors or stress.

When should L30.1 be used instead of related codes?

L30.1 should be used when the clinical presentation aligns with dyshidrosis, particularly when vesicular lesions are present on the hands and feet, differentiating it from other dermatitis types.

What documentation supports L30.1?

Documentation should include a detailed patient history, clinical examination findings, treatment responses, and any identified triggers or allergens that may contribute to the condition.